O'Dowd Hugh
Insider CIK 1741171 · PBYI Director · NTGN President & CEO, Director · TXMD President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2022-03-31 | 2022-03-31 | 2,125,000 | — | $0 | 2,125,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2022-03-23 | 2022-03-28 | 2,125,000 | — | $0 | 2,125,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-08-31 | 2021-08-31 | 2,750,000 | — | $0 | 2,750,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-08-31 | 2021-08-31 | 2,750,000 | — | $0 | 2,750,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2020-06-09 | 2020-06-11 | 25,748 | — | $0 | 25,748 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 208,062 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 200,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 354,632 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer | 2020-05-06 | 2020-05-06 | 776,085 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-29 | 2020-03-02 | 9,783 | $1.50 | $14.7K | 776,085 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2020-01-12 | 2020-01-13 | 240,000 | — | $0 | 785,868 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2019-10-15 | 2019-10-17 | 85,201 | — | $0 | 85,201 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-02-27 | 2019-03-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-02-27 | 2019-03-01 | 100,000 | — | $0 | 545,868 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | M Exercise deriv | 2018-08-20 | 2018-08-22 | 18,868 | — | $0 | 314,607 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | M Exercise | 2018-08-20 | 2018-08-22 | 18,868 | $2.65 | $50.0K | 445,868 | SEC↗ |